Microglia and HPA axis in depression: An overview of participation and relationship

World J Biol Psychiatry. 2022 Mar;23(3):165-182. doi: 10.1080/15622975.2021.1939154. Epub 2021 Jul 7.

Abstract

Objectives: This narrative review article provides an overview on the involvement of microglia and the hypothalamic-pituitary-adrenal (HPA) axis in the pathophysiology of depression, as well investigates the mutual relationship between these two entities: how microglial activation can contribute to the dysregulation of the HPA axis, and vice versa.Methods: Relevant studies and reviews already published in the Pubmed electronic database involving the themes microglia, HPA axis and depression were used to meet the objectives.Results: Exposition to stressful events is considered a common factor in the mechanisms proposed to explain the depressive disorder. Stress can activate microglial cells, important immune components of the central nervous system (CNS). Moreover, another system involved in the physiological response to stressors is the hypothalamic-pituitary-adrenal (HPA) axis, the main stress response system responsible for the production of the glucocorticoid hormone (GC). Also, mediators released after microglial activation can stimulate the HPA axis, inducing production of GC. Likewise, high levels of GCs are also capable of activating microglia, generating a vicious cycle.Conclusion: Immune and neuroendocrine systems seems to work in a coordinated manner and that their dysregulation may be involved in the pathophysiology of depression since neuroinflammation and hypercortisolism are often observed in this disorder.

Keywords: Neuroinflammation; glucocorticoid; stress.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Depression
  • Glucocorticoids
  • Humans
  • Hypothalamo-Hypophyseal System*
  • Microglia
  • Pituitary-Adrenal System*
  • Stress, Psychological

Substances

  • Glucocorticoids